Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1624 1625
This examiner grants 81% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18818183 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | Non-Final OA | LG CHEM, LTD. |
| 18262256 | USES OF MELANOCORTIN-4 RECEPTOR AGONIST | Final Rejection | LG CHEM, LTD. |
| 18258705 | AMORPHOUS MELANOCORTIN RECEPTOR AGONIST AND METHOD FOR PREPARING SAME | Final Rejection | LG CHEM, LTD. |
| 18922313 | ANACARDIC ACID FOR INFLAMMATORY CONDITIONS | Non-Final OA | Vanderbilt University |
| 18041627 | Methods and Compositions for Inhibiting Viral Infection | Non-Final OA | New York University |
| 18551614 | PROCESS FOR PREPARING (2Z)-2-(PHENYLIMINO)-1,3-THIAZOLIDINE-4-ONE-SULFOXIDE DERIVATIVES IN AN ENANTIOMERICALLY ENRICHED FORM | Non-Final OA | Bayer Aktiengesellschaft |
| 17911673 | H2O2 WITHOUT DIBC FOR PO PRODUCTION | Non-Final OA | Dow Global Technologies LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy